The University of Oxford

Dr Shijie Cai

Based on a fruitful ongoing research project in collaboration with Chinese colleagues, Oxford research scientists have recently set up a research team focusing on cholangiocarcinoma.  This new Oxford Cholangiocarcinoma Research Team includes,medical oncologists, hepatobiliary surgeons, molecular pathologists and research scientists. They intend to investigate the proteomics and metabolism of cholangiocarcinoma for drug development and potential clinical trials.

In their AMMF funded work, they propose to identify the USP22 protein interactome and its associated metabolic changes on cholangiocarcinoma growth and invasion. Successful outcomes of this study would be evidence identifying targets/pathways and supporting further development of small molecule inhibitors in the future.

Back to: AMMF Grants for Research